Stock Events

Stock Events

Voyageur Pharmaceuticals 

C$0.12
4
+C$0+4.35% Tuesday 15:20

Statistics

Day High
0.14
Day Low
0.12
52W High
0.36
52W Low
0.1
Volume
76,100
Avg. Volume
79,131
Mkt Cap
21.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24AprExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-3.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VM.V. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medical products including those in the mineral and healthcare sectors similar to Voyageur Pharmaceuticals.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceutical industry, developing drugs and treatments that may overlap with the mineral-based products offered by Voyageur Pharmaceuticals.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. operates in the pharmaceutical sector, producing health solutions that can compete with the mineral-based pharmaceuticals developed by Voyageur.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on a broad range of pharmaceutical products, potentially competing in the same healthcare segments as Voyageur Pharmaceuticals.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, with its extensive range of pharmaceutical products, competes in various therapeutic areas that might intersect with Voyageur’s offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. competes in the global pharmaceutical market, potentially overlapping with Voyageur’s niche in mineral-based pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb operates in multiple pharmaceutical areas, which could include competition in sectors targeted by Voyageur Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops a wide array of pharmaceutical products that could compete with Voyageur’s specialized mineral-based treatments.
Sanofi
SNY
Mkt Cap124.45B
Sanofi engages in the development and marketing of pharmaceutical products that may compete with the offerings from Voyageur Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates globally in various pharmaceutical sectors, potentially competing with Voyageur Pharmaceuticals in certain healthcare markets.

About

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Show more...
CEO
Mr. Brent Willis Bsc.Eng
Country
CA
ISIN
CA92918C1014

Listings

OTC Link
US
VYYRF
V
CA
VM.V

0 Comments

Share your thoughts

FAQ

What is Voyageur Pharmaceuticals stock price today?▼
The current price of VM.V is C$0.12 CAD — it has increased by +4.35% in the past 24 hours. Watch Voyageur Pharmaceuticals stock price performance more closely on the chart.
What is Voyageur Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Voyageur Pharmaceuticals stocks are traded under the ticker VM.V.
Is Voyageur Pharmaceuticals stock price growing?▼
VM.V stock has risen by +4.35% compared to the previous week, the month change is a -25% fall, over the last year Voyageur Pharmaceuticals has showed a -36.84% decrease.
What is Voyageur Pharmaceuticals market cap?▼
Today Voyageur Pharmaceuticals has the market capitalization of 21.4M
When is the next Voyageur Pharmaceuticals earnings date?▼
Voyageur Pharmaceuticals is going to release the next earnings report on April 24, 2026.
What is Voyageur Pharmaceuticals revenue for the last year?▼
Voyageur Pharmaceuticals revenue for the last year amounts to 0 CAD.
What is Voyageur Pharmaceuticals net income for the last year?▼
VM.V net income for the last year is -3.41M CAD.
In which sector is Voyageur Pharmaceuticals located?▼
Voyageur Pharmaceuticals operates in the Health Care sector.
When did Voyageur Pharmaceuticals complete a stock split?▼
The last stock split for Voyageur Pharmaceuticals was on March 07, 2017 with a ratio of 1:2.
Where is Voyageur Pharmaceuticals headquartered?▼
Voyageur Pharmaceuticals is headquartered in Calgary, CA.